FDA Grants Priority Review to Pfizer's RSV Vaccine Candidate for Older Adults

Retrieved on: 2022-12-08 15:09:06

Tags for this article:

Click the tags to see associated articles and topics

FDA Grants Priority Review to Pfizer's RSV Vaccine Candidate for Older Adults. View article details on hiswai:

Excerpt

The FDA has granted priority review to a Biologics License Application (BLA) for Pfizer's respiratory syncytial virus (RSV) vaccine candidate, ...

Article found on: www.pharmacytimes.com